Skip to main content
PB

Pasture Biosciences

Pasture Biosciences develops next-generation veterinary vaccines for livestock health and sustainability. Their flagship product is a cattle vaccine designed to improve feed efficiency by targeting methane-producing microbes in the rumen. This technology aims to enhance cattle performance while significantly reducing enteric methane emissions.

San Francisco, United States6500+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Methane emissions from cattle, primarily released through burping, significantly contribute to climate change, with bovine enteric fermentation accounting for a substantial portion of human-linked methane emissions globally. The increasing demand for meat and dairy products necessitates a solution to mitigate the environmental impact of cattle farming.

Solution

Pasture Biosciences is developing a vaccine designed to target and reduce methane-producing microbes within a cow's gut. This innovative approach aims to decrease methane emissions from cattle, offering a sustainable solution for the dairy and beef industries to reduce their greenhouse gas footprint. By vaccinating cattle, Pasture Biosciences seeks to enable farmers and ranchers to meet the growing global demand for food while minimizing the detrimental effects on the environment, regardless of the farming system employed.

Target Audience

The primary target audience includes dairy farmers and cattle ranchers seeking to reduce the environmental impact of their operations and contribute to more sustainable food production.

Features

  • Vaccine targets methane-producing microbes in the cow's gut.
  • Designed for both beef and dairy cattle.
  • Aims to reduce methane emissions released through burping.
  • Supports sustainable farming practices.
This profile is AI-generated and may contain inaccuracies.